Thymoma epidemiology and demographics

Revision as of 19:39, 21 September 2015 by Ahmad Al Maradni (talk | contribs) (→‎Age)
Jump to navigation Jump to search

Thymoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thymoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thymoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymoma epidemiology and demographics

CDC on Thymoma epidemiology and demographics

Thymoma epidemiology and demographics in the news

Blogs on Thymoma epidemiology and demographics

Directions to Hospitals Treating Thymoma

Risk calculators and risk factors for Thymoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2] Ahmad Al Maradni, M.D. [3]

Overview

The incidence of thymoma is approximately 0.13 per 100,000 individuals. Thymic neoplasms are the most common tumors located in the anterior mediastinum (20%). Incidence increases in middle age, and peaks in the seventh decade of life. Men and women are equally affected.

Incidence

The incidence of thymoma is 0.13 per 100,000 individuals.

Age and Race

Thymoma is very uncommon in children and young adults, incidence raises in middle age, and peaks in the seventh decade of life. The highest frequency of diagnosis is found to be among the 30-50 year age group. For unknown reasons, it highly predominates among Asians and Pacific Islanders in the U.S.[1]

Gender

Men and women are equally affected.[2]

References

  1. "Epidemiology of thymoma and associated malignancies".
  2. Thomas CR, Wright CD, Loehrer PJ (1999). "Thymoma: state of the art". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17 (7): 2280–9. PMID 10561285. Text "accessdate" ignored (help); Unknown parameter |month= ignored (help)

Template:WikiDoc Sources